Cargando…
Eculizumab for acute relapse of neuromyelitis optica spectrum disorder: Case report
INTRODUCTION: Eculizumab has been shown to be an effective and typically well-tolerated medication in the treatment of neuromyelitis optica spectrum disorder (NMOSD) in maintaining disease remission in patients who are aquaporin-4 water channel autoantibody (AQP4-IgG) seropositive. The efficacy of e...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393544/ https://www.ncbi.nlm.nih.gov/pubmed/36003301 http://dx.doi.org/10.3389/fneur.2022.951423 |